Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations

17 May, 2022 from 18:00–19:00

• Chair: Prof. Jens-Ulrik Stæhr Jensen (Copenhagen, Denmark)
• Speakers: Dr. Alexander Mathioudakis (Manchester, United Kingdom), Prof. Jens-Ulrik Stæhr Jensen (Copenhagen, Denmark)
• Fees: Free for ERS members / €10 for non-members

CESTChaired by Jens-Ulrik Stæhr Jensen, this webinar features guest speaker Alexander Mathioudakis. This session will explore the challenges that researchers face when conducting clinical trials of COPD exacerbations management. It will focus on the importance of core outcome sets and will describe the ERS COPD exacerbations core outcome set and how it was developed.

• What delays the introduction of new effective treatments for COPD exacerbations?
• What is a core outcome set and why it is important?
• How was the ERS Core Outcome Set for COPD Exacerbations Management developed?
• Which outcomes are included in the ERS COPD Exacerbations Core Outcome Set?
• How should they be assessed?

Link to registration